PREVIOUS POSITION

Responsible for building and leading a world class Bioprocess R&D organization at the Merck Research Laboratories.  During this period, mostly as Vice President, Barry was involved in the development, transfer to manufacturing, licensure and launch for many key products including :

• MEVACOR ® (A natural product used for cholesterol lowering)
  

• ZOCOR ® (Derived from Mevacaor)
  

• IVOMEC ® (Anti parasitic drug for both animals and humans)
  

• CANCIDAS ® (A natural product with excellent anti fungal activity)
  

• RECOMBIVAX HB ® (Vaccine against Hepatitis B)
  

• VAQTA ® (Hepatitis A Vaccine)
  

• VARIVAX ® (Chicken pox vaccine)
  

• COMVAX ® (Combination pediatric vaccine)
  

• ROTATEQ ® (Rotavirus vaccine for infant diarrhea)
  

• ZOSTAVAX ® (Vaccine against shingles)
  

• GARDASIL ® (Vaccine against Human Papillomovirus HPV)